Core Viewpoint - Fengbei Bio (603334) has experienced significant stock price fluctuations, with a recent increase of 25.93% to 59.3 yuan as of February 6, 2026, indicating strong market interest and trading activity [1][8]. Trading Information Summary - Fengbei Bio was listed on the "Dragon and Tiger List" for two consecutive days due to a daily turnover rate reaching 20% on February 5 and 6, 2026, marking its second appearance in the last five trading days [2][5]. - The stock also saw a cumulative price deviation exceeding 20% over two consecutive trading days, indicating abnormal trading activity [8]. Company Development and Products - Established in 2014, Fengbei Bio focuses on the comprehensive utilization of waste oil resources and has entered a rapid growth phase since 2018, emphasizing bio-based materials and biofuels [3]. - The main business includes waste oil resource utilization, with products such as bio-based materials (e.g., pesticide and fertilizer additives) and biofuels (e.g., biodiesel) [3][4]. - In the first half of 2025, the company produced 47,706.75 tons of biodiesel and 142,814.10 tons of industrial-grade mixed oil [4][5]. Market and Regulatory Environment - The company holds ISCC certification, allowing it to enter the EU market, which has stringent requirements for biofuel products [6]. - The revised Renewable Energy Directive (RED) aims to increase the EU's renewable energy target to at least 42.5% by 2030, impacting the biofuel market [6]. Client Relationships - Fengbei Bio collaborates with major global commodity traders and end customers, including TRFIGUR, GLENCORE, and SHELL, for its biodiesel sales [6]. - The company has established partnerships with key SF manufacturers for the sale of industrial-grade mixed oil [6]. Raw Material Sourcing - Waste oil is sourced from food processing, chemical companies, and kitchen waste treatment enterprises, with a nationwide supply network and efforts to expand overseas [7].

会议演讲/路演报名（审核制） 请添加下方微信 声明： 因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文由仅作新材料相关领域介绍，本文不构成任何投资 建议！转载请注明来源！ 近日， 丰倍生物 （ 603334）接受投资者调研时表示，其生产的 生物柴油 主要用于对外销售和进一步 复配成生物柴油配方产品 ，同时2024年起随着公司对上游原料端的持续布局， 加大了工业级混合油对 外销售规模 。 公司2025年1-6月公司 生物柴油 产量为 47,706.75吨， 工业级混合油 产量为142,814.10 吨 。 据悉， 丰倍生物成立于2014年，是一家废弃资源综合利用领域的高新技术企业，主要以废弃油脂生产 资源化产品 。基于长期的研发投入和产业实践，公司在废弃油脂资源综合利用的深度及广度上不断拓 展，形成了 "废弃油脂—生物燃料（生物柴油）—生物基材料" 的废弃资源再生产业链。此外，公司还 依托自身油脂综合利用核心技术和渠道优势为客户提供油脂化学品。 其废弃油脂 主要来源于粮油食品加工企业、油脂化工企业、餐厨处理企业 等。公司在全国范围内多点 布局知名粮油食品加工企业、油脂化工企业、餐厨处理企业、 区 ...

Core Viewpoint - The article discusses the tax incentives provided by the government to promote the recycling and utilization of renewable resources, which are crucial for rural revitalization and agricultural economic development. Group 1: Tax Incentives for Biomass and Renewable Resources - From March 1, 2022, a 100% VAT refund policy is implemented for products made from specific renewable resources such as kitchen waste, animal manure, and agricultural residues [4] - Taxpayers must obtain VAT invoices for the recycled resources purchased domestically to qualify for the refund policy [5] - The sales revenue from products that do not meet the invoice requirements will not be eligible for the VAT refund [5][12] Group 2: Conditions for Enjoying Tax Benefits - Taxpayers must maintain a record of the recycled resources acquired, including supplier details, resource type, quantity, price, and whether VAT invoices were obtained [6] - The products sold must not fall under the categories of eliminated or restricted projects as per the industrial structure adjustment guidance [6] - The products must not be classified as high pollution or high environmental risk according to the environmental protection catalog [6] Group 3: Specific Tax Refund Policies - A 90% VAT refund policy applies to products made from agricultural residues such as straw and corn cobs [11] - A 70% VAT refund policy is available for biodiesel and industrial-grade mixed oil produced from waste animal and plant oils [18] - A 50% VAT refund policy is applicable for paper pulp and paper produced from agricultural straw [26] Group 4: Compliance and Regulatory Requirements - Taxpayers must not have received administrative penalties for violating environmental protection laws in the six months prior to applying for the tax refund [8] - Taxpayers must provide a written declaration to the tax authority confirming compliance with the relevant technical standards and conditions [8][14] - The raw materials used in the products must consist of at least 70% from the specified renewable resources [15][39]

Core Viewpoint - Fengbei Bio (603334) is engaged in selling industrial-grade mixed oil to SAF (Sustainable Aviation Fuel) companies, which is further processed by downstream customers into SAF [1] Group 1: Company Overview - The company’s business includes the sale of industrial-grade mixed oil derived from waste oils, which is standardized according to customer requirements [1] - The industrial-grade mixed oil can be utilized in the production of biodiesel and biojet fuel [1]

Group 1 - The core point of the article is that Shanggao Environmental Energy announced a government subsidy of 2.33 million yuan, which accounts for 17.87% of the company's most recent audited net profit [1] - For the first half of 2025, the revenue composition of Shanggao Environmental Energy is as follows: industrial-grade mixed oil processing and sales accounted for 51.67%, heating industry for 24.29%, environmental harmless treatment for 23.76%, and other businesses for 0.28% [1] - As of the report date, the market capitalization of Shanggao Environmental Energy is 3.4 billion yuan [1]

Core Viewpoint - The rapid decline of Fengbei Bio's stock price by nearly 30% within three days of its IPO raises concerns about the company's financial health and governance, particularly as the actual controller has already cashed out over 65 million yuan before the stock plunge [3][7]. Financial Performance - Fengbei Bio's revenue increased from 1.709 billion yuan in 2022 to 1.949 billion yuan in 2024, but net profit attributable to shareholders decreased from 133 million yuan to 124 million yuan, marking two consecutive years of negative growth [3]. - The company's cash flow from operating activities plummeted by 86.2%, from 162 million yuan in 2023 to 22.43 million yuan in 2024, and further deteriorated to -7.5 million yuan in the first half of 2025 [4][5]. Profitability Issues - The gross profit margin has been declining sharply, from 13.95% in 2023 to 9.50% in the first half of 2025, primarily due to an increase in the sales proportion of low-margin industrial-grade mixed oil [5][7]. Trade Barriers Impact - The imposition of a 23.7% anti-dumping tax by the EU in July 2024 led to a drastic reduction in exports, with export revenue dropping from 434 million yuan in 2023 to 50.51 million yuan in 2024, a decline of over 85% [7]. - The average selling price of biofuels decreased by 25.51% from 9,800 yuan per ton in 2022 to 7,300 yuan per ton in 2024, alongside significant price drops in bio-based materials and chemical oils [7]. Expansion Strategy Concerns - Despite a decline in capacity utilization from 99.84% in 2023 to 76.31% in 2024, Fengbei Bio plans to raise 750 million yuan for capacity expansion projects, which may lead to increased depreciation and amortization costs of approximately 58 million yuan annually [8]. - The company's expansion strategy is risky as it heavily relies on market demand, which is currently showing signs of oversupply [8]. Regulatory and Compliance Issues - Fengbei Bio's subsidiaries have faced multiple environmental compliance issues, being listed as key pollutant units and ordered to rectify environmental problems [10]. - There are ongoing legal issues related to a fire incident causing significant inventory loss, and past actions involving questionable financial practices raise concerns about regulatory compliance [10][13]. Market Sentiment and Risks - Historical data indicates that new stocks with a first-day increase of over 150% have a high likelihood of declining in the following months, with an average drop of 27% after one month and 28% after three months [12]. - The company's IPO has become a cautionary tale for investors regarding the risks associated with speculative trading in newly listed stocks [13].

Core Viewpoint - Fengbei Bio (603334.SH) experienced a significant decline in stock price, closing at 57.13 yuan, down 14.42% on November 6, 2023 [1] Group 1: IPO Details - Fengbei Bio was listed on the Shanghai Stock Exchange on November 5, 2025, with an issuance of 35.9 million shares, all new shares, at a price of 24.49 yuan per share [1] - The total funds raised from the issuance amounted to 879.191 million yuan, with a net amount of 794.438 million yuan after deducting issuance costs, exceeding the original plan by 44.438 million yuan [1] Group 2: Fund Utilization - The company disclosed in its prospectus on October 31 that it plans to use the raised funds of 750 million yuan for several projects, including the construction of a 300,000-ton annual production facility for oleic acid methyl ester, a 10,000-ton industrial-grade mixed oil facility, a 50,000-ton agricultural microbial agent facility, a 10,000-ton compound microbial fertilizer facility, and by-products including 50,000 tons of biodiesel and 8,200 tons of glycerin [1] Group 3: Issuance Costs - The total issuance costs for the public offering amounted to 84.7533 million yuan (excluding VAT), with underwriting fees accounting for 58.0598 million yuan [1]

Core Viewpoint - The A-share biodiesel sector experienced a significant surge, driven by the strong debut of Fengbei Bio on the Shanghai Stock Exchange and increasing global support for sustainable aviation fuel (SAF) procurement and application, indicating a positive outlook for the biodiesel industry chain [1] Industry and Company Summary - Fengbei Bio, a high-tech enterprise in the field of waste resource utilization, focuses on producing resource-based products from waste oils. The company has established a stable partnership with HXN Energy, which is expected to be its second-largest customer by mid-2025, benefiting from the rising demand for industrial-grade blended oils due to the SAF and biodiesel industry [2] - HXN Energy has been deeply involved in the biodiesel industry for years, aiming to become a global leader in green energy and chemical products. The company is enhancing its raw material supply system and plans to expand its biodiesel raw material sources while improving procurement transparency and controlling costs [4] - According to the International Energy Agency (IEA), global biodiesel consumption is projected to grow from approximately 42.42 million tons in 2023 to 59.93 million tons by 2028, reflecting a compound annual growth rate of about 7.16%. Both Fengbei Bio and HXN Energy are positioned to benefit from this growth in global biodiesel demand [7] - Policy initiatives are creating new opportunities in the bioenergy sector, with countries expanding the application of biofuels in various transportation modes. For instance, Singapore's new legislation mandates that departing flights must use at least 1% SAF starting in 2026, increasing to 3-5% by 2030, marking a significant step in decarbonizing transportation [8] - The European market is expected to be a core area for biodiesel demand, with the EU set to implement large-scale SAF blending mandates starting in 2025. The International Maritime Organization's strategy aims for net-zero greenhouse gas emissions from ships by 2050, further driving the demand for biodiesel as a shipping fuel [9]

Core Viewpoint - Fengbei Biotechnology Co., Ltd. has successfully listed on the Shanghai Stock Exchange, with a significant opening price increase and high trading volume, indicating strong market interest and investor confidence in the company [1]. Company Overview - Fengbei Biotechnology is a high-tech enterprise focused on the comprehensive utilization of waste resources, primarily producing resource-based products from waste oils [2]. - The controlling shareholder and actual controller of the company is Pingyuan, who directly holds 44.82% of the shares post-IPO and controls a total of 64.03% of the shares through indirect holdings [2]. Financial Performance - The company reported revenues of 170,869.32 million yuan, 172,778.32 million yuan, and 194,801.63 million yuan for the years 2022, 2023, and 2024 respectively, showing a steady growth trend [6]. - Net profits attributable to the parent company were 13,334.79 million yuan, 12,971.18 million yuan, and 12,381.99 million yuan for the same years, indicating a slight decline in profitability [6]. - For the first nine months of 2025, the company achieved revenues of 225,140.52 million yuan, a year-on-year increase of 62.32%, and a net profit of 11,729.88 million yuan, up 35.32% from the previous year [8][9]. IPO Details - The company issued 35.90 million new shares at an issue price of 24.49 yuan per share, raising a total of 879.191 million yuan, with a net amount of 794.438 million yuan after deducting issuance costs [4]. - The funds raised will be used for projects including the construction of production facilities for various bio-based products [4][5]. Future Outlook - The company plans to adjust its customer and product structure in 2024 while maintaining revenue growth, with a focus on managing sales and administrative expenses effectively [3]. - There are inquiries regarding the sustainability of revenue from biofuels and the growth potential of industrial-grade mixed oil sales, indicating a need for careful monitoring of market conditions and operational stability [3].

Core Viewpoint - Company N Fengbei has successfully listed with an opening price of 66.00 yuan, reflecting a significant increase of 169.50% on its first trading day, indicating strong market interest and investor confidence in the company's business model and growth potential [2]. Company Overview - N Fengbei is a high-tech enterprise in the field of comprehensive utilization of waste resources, primarily focusing on the production of resource-based products from waste oils [2]. - The company has developed a production chain that includes waste oils, biodiesel, and bio-based materials, showcasing its commitment to sustainability and innovation in waste resource recycling [2]. Financial Performance - The total number of shares issued by the company is 35.90 million, with an online issuance of 24.21 million shares at a price of 24.49 yuan per share [2]. - The company's issuance price corresponds to a price-to-earnings (P/E) ratio of 30.47, which is significantly lower than the industry average P/E ratio of 64.73 [2]. - The total funds raised from the initial public offering (IPO) amount to 879 million yuan, which will be allocated to projects including the construction of a 300,000-ton annual production facility for methyl oleate, among others [2]. Recent IPO Performance - N Fengbei's first-day performance is part of a broader trend of newly listed stocks, with several companies experiencing substantial increases in their opening prices, indicating a robust market for IPOs in various sectors [3].